Join
Live feed
·
PRReleasevia Quantisnow
Rexahn Pharmaceuticals, Inc. logo

Rexahn Pharmaceuticals Announces Stockholder Approval of All Proposals Required for Merger with Ocuphire Pharma

ByQuantisnow·Wall Street's wire, on your screen.
Full content unavailable. See the original source below.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track REXN (Rexahn Pharmaceuticals, Inc.) and more on Quantisnow.